IgA nephropathy: open trials in Hong Kong

• NCT06963827

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Trial Treatment · Phase 3 · Takeda

  The University of Hong Kong, Department of Medicine, Hong Kong

  Registry updated 2026-11-04

• NCT06989359

  Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

  Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.

  Hong Kong · Shatin

  Registry updated 2026-10-20

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Hong Kong

  Registry updated 2026-10-05

• NCT06994845

  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Hong Kong

  Registry updated 2026-09-09

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error